Transbiomed, the first spin-off developed at Vall d’Hebron Institute of Research (VHIR), led by Dr. Jaume Reventós, head of the Research Unit in Biomedicine and Translational Oncology, was presented as an example of success yesterday at the first day of "http://www.mihealthforum.com/" MIHealth Forumon innovation and management in health. During these days, several media have talked about this spin-off whose aim is developing medical diagnostic devices. One of them is the Catalan Television TV3, where Dr. Reventós insisted on the importance of knowledge transfer from the lab to the market in the field of health: “Our findings should not finish in the papers. Our research should arrive to the market and become a product useful for our health system”. Transbiomed was founded in 2007 and started its activity thanks to a risk capital investment. Now, from the 26th to the 28th of June, Barcelona will be the center of discussion and sharing of experiences in clinical innovation and new models of health management with the aim to improve the health system, the attention to patients, and to attract private investors to make it possible.VHIR’s director, Dr. Joan X. Comella, is a member of the scientific committee of MIHealth, and the head of knowledge transfer and innovation at VHIR, Raquel Egea, will be a leader session in this congress that will take place at Palau de Congressos de Barcelona.Congressos de Barcelona.